89 completed, 22 terminated, 15 unknown, 14 active not recruiting. 70 Phase 2, 41 Phase 1, 33 Phase 3, 21 Not applicable, 2 Early Phase 1.
Follow Radiotherapy, Conformal: new trials by email Literature Review of Radiotherapy, Conformal trials Research Report on Radiotherapy, Conformal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma 3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection - Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | National Cancer Institute (NCI) | 374 | 2026-12-04 | 2026-07-08 |
| Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Computed Tomography - Recurrent Soft Tissue Sarcoma of the Trunk and Extremities, Resectable Soft Tissue Sarcoma of the Trunk and Extremities | Phase 3 | Recruiting | SWOG Cancer Research Network | 296 | 2026-12-02 | 2026-10-13 |
| A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma Bicalutamide, Intensity-modulated radiation therapy (IMRT) - Recurrent Glioblastoma, Recurrent High-grade Glioma | Phase 1 | Withdrawn | University of Nebraska | 2025-04-08 | 2025-07-22 | |
| A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma 3-Dimensional Conformal Proton Radiation Therapy, 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection - Basal Ganglia Germinoma, Diabetes Insipidus | Phase 2 | Recruiting | Children's Oncology Group | 240 | 2024-10-22 | 2026-08-25 |
| Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma 3-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy (IMRT), Temozolomide - Glioblastoma, Gliosarcoma | Phase 1 | Terminated | Barbara Ann Karmanos Cancer Institute | 2 | 2021-08-12 | 2025-01-15 |
| Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. Hypofractionated radiotherapy - Ductal Breast Carcinoma in Situ, Invasive Breast Cancer | Not applicable | Active not recruiting | Coordinación de Investigación en Salud, Mexico | 72 | 2021-04-26 | 2026-03-23 |
| Propranolol With Chemotherapy or Chemoradiation for Esophageal Adenocarcinoma Carboplatin, 3 Dimensional Conformal Radiation Therapy, Propranolol - Esophageal Adenocarcinoma | Phase 2 | Recruiting | Roswell Park Cancer Institute | 106 | 2021-04-01 | 2026-10-22 |
| Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers 3-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, Quality-of-Life Assessment - Metastatic Malignant Female Reproductive System Neoplasm | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 28 | 2021-01-11 | 2026-10-30 |
| A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) 3-Dimensional Conformal Radiation Therapy, Asparaginase Erwinia chrysanthemi, Biospecimen Collection - Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 461 | 2020-12-17 | 2026-09-01 |
| Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging 3-Dimensional Conformal Radiation Therapy, Apalutamide, Computed Tomography - Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 3 | Recruiting | ECOG-ACRIN Cancer Research Group | 804 | 2020-10-08 | 2026-08-19 |
| Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer Thoracic RT and Durvalumab, Consolidative Durvalumab - Non Small Cell Lung Cancer, Lung Cancer Stage III | Phase 2 | Completed | University of Texas Southwestern Medical Center | 10 | 2020-04-03 | 2025-03-21 |
| TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer 3-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, Trifluridine and Tipiracil Hydrochloride - Rectal Adenocarcinoma, Stage IIA Rectal Cancer AJCC v8 | Phase 1 | Completed | OHSU Knight Cancer Institute | 19 | 2019-12-11 | 2026-08-06 |
| Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) 3-Dimensional Conformal Radiation Therapy, Atezolizumab, Biospecimen Collection - Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 544 | 2019-07-26 | 2026-08-27 |
| Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer 3-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 | Not applicable | Active not recruiting | Ohio State University Comprehensive Cancer Center | 61 | 2019-01-09 | 2026-03-19 |
| A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation Paclitaxel, Carboplatin, Dexamethasone - Gastric Cancer, Stomach Cancer | Phase 2 | Unknown | Icahn School of Medicine at Mount Sinai | 29 | 2018-12-03 | 2023-11-14 |
| Stereotactic Body Radiotherapy Boost After Palliative Radiotherapy for Spinal Cord Compression 3D CRT plus SBRT boost - Spinal Cord Compression, Cauda Equina Syndrome | Not applicable | Unknown | Juravinski Cancer Center | 30 | 2018-06-01 | 2020-01-29 |
| PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer Radiotherapy, Pembrolizumab, Chemotherapy - Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic | Phase 3 | Active not recruiting | UNICANCER | 327 | 2018-01-24 | 2026-02-25 |
| TILA-TACE in Treatment of Hepatocellular Carcinoma TILA-TACE treatment - Tumor Response Rate, Overall Survival | Not applicable | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2000 | 2017-11-01 | 2019-04-10 |
| Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas LITT, Radiation therapy, Temozolomide - High Grade Glioma | Early Phase 1 | Completed | Case Comprehensive Cancer Center | 13 | 2017-08-24 | 2026-08-06 |
| NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma NovoTTF-200A, Temozolomide, 3D conformal or intensity modulated radiation therapy (IMRT) - Glioblastoma, Adult | Phase 1 | Completed | Hackensack Meridian Health | 12 | 2017-07-26 | 2024-11-18 |
Showing 20 of 150. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (22) · Glioblastoma (14) · Gliosarcoma (13) · Prostatic Neoplasms (12) · Breast Neoplasms (11) · Squamous Cell Carcinoma of Head and Neck (11) · Head and Neck Neoplasms (10) · Lung Neoplasms (9) · Pancreatic Neoplasms (9) · Brain Neoplasms (7) · Adenocarcinoma of Lung (6) · Astrocytoma (5) · Salivary Gland Neoplasms (5) · Adenocarcinoma, Bronchiolo-Alveolar (4) · Carcinoma, Intraductal, Noninfiltrating (4)
National Cancer Institute (NCI) (28) · Radiation Therapy Oncology Group (16) · Children's Oncology Group (12) · Gynecologic Oncology Group (5) · Cancer Trials Ireland (4) · European Organisation for Research and Treatment of Cancer - EORTC (4) · Case Comprehensive Cancer Center (3) · M.D. Anderson Cancer Center (3) · NRG Oncology (3) · UNICANCER (3) · University of Washington (3) · Abramson Cancer Center at Penn Medicine (2) · Fudan University (2) · Institute of Cancer Research, United Kingdom (2) · NCIC Clinical Trials Group (2)
United States (111) · Canada (35) · Australia (13) · Switzerland (13) · China (9) · Israel (9) · France (8) · New Zealand (8) · United Kingdom (7) · Puerto Rico (6) · Ireland (5) · Belgium (4) · Germany (3) · Italy (3) · Netherlands (3)
Oliver Sartor, MD (3) · Pierre Thirion, MD (3) · Christopher H. Crane, MD (2) · Elizabeth A Mullen (2) · Adam P. Dicker, MD, PhD (1) · Alan Pollack, MD, PhD (1) · Alberto Biggi, MD (1) · Alessio G Morganti, Professor (1) · Alex Adjei (1) · Alexander Colevas (1) · Alyssa T Reddy (1) · Amy A Smith (1) · Andrew J Davies, MD (1) · Andrew Poklepovic, MD (1)
PMID 36884035, PMID 31449468, PMID 37751207, PMID 10661346, PMID 11208820, PMID 12694838, PMID 14529764, PMID 14967428, PMID 14967461, PMID 15142632, PMID 15590164, PMID 1584260, PMID 15936549, PMID 16425991, PMID 16467544, PMID 17825932, PMID 18955445, PMID 19304957, PMID 19577865, PMID 19695049, PMID 20056794, PMID 20381270, PMID 20413658, PMID 20598811, PMID 21377288, PMID 21414514, PMID 22178121, PMID 22342302, PMID 22633552, PMID 22673726, PMID 23045594, PMID 23139259, PMID 23460709, PMID 23474363, PMID 23678006, PMID 24064318, PMID 24064970, PMID 24552317, PMID 25057165, PMID 25074417, PMID 25105369, PMID 25592642, PMID 25633805, PMID 25832688, PMID 25964250, PMID 26328939, PMID 26493095, PMID 26561342, PMID 26590194, PMID 27044935
U10CA098543 (12), U10CA180868 (10), U10CA021661 (9), U10CA180886 (9), U10CA027469 (6), U10CA025224 (4), P30CA043703 (3), N01CM62201 (2), U01CA069856 (2), U01CA076576 (2), U01CA081457 (2), U10CA032102 (2), U10CA180820 (2), U10CA180821 (2), U10CA180888 (2)